🚚 FREE U.S. Shipping on Orders Over $500
SKU: Oxytocin-5mg

OXYTOCIN (5MG)

Oxytocin is a cyclic nonapeptide with the sequence Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH₂, containing an intramolecular disulfide bridge between the cysteine residues at positions 1 and 6 and a C-terminal amide. The disulfide forms a six-residue ring with a three-residue tail.

In published literature, oxytocin has been characterized as an agonist at the oxytocin receptor (OXTR), a class A G protein-coupled receptor, with cross-reactivity at vasopressin receptor subtypes. This material is supplied as a characterized reference compound for non-clinical laboratory work, such as analytical method development for disulfide-containing cyclic peptides, OXTR receptor binding and calcium-mobilization assays, receptor selectivity profiling against vasopressin receptors, immunoassay calibration, and disulfide mapping.

Compound Specifications

  • Sequence: Cys¹-Tyr-Ile-Gln-Asn-Cys¹-Pro-Leu-Gly-NH₂ (disulfide bridge Cys1-Cys6)
  • Sequence Length: 9 residues (cyclic nonapeptide)
  • Molecular Formula: C₄₃H₆₆N₁₂O₁₂S₂
  • Molecular Weight: ~1007.2 g/mol
  • CAS Number: 50-56-6
  • PubChem CID: 439302
  • Physical Form: Lyophilized powder

 

Storage & Handling
Store lyophilized powder at −20 °C, protected from light. Avoid moisture and repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety practices.

FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

 

$55.00

Choose Quantity

Description

Oxytocin is a cyclic nonapeptide with the sequence Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH₂, containing an intramolecular disulfide bridge between the cysteine residues at positions 1 and 6 and a C-terminal amide. The disulfide forms a six-residue ring with a three-residue tail.

In published literature, oxytocin has been characterized as an agonist at the oxytocin receptor (OXTR), a class A G protein-coupled receptor, with cross-reactivity at vasopressin receptor subtypes. This material is supplied as a characterized reference compound for non-clinical laboratory work, such as analytical method development for disulfide-containing cyclic peptides, OXTR receptor binding and calcium-mobilization assays, receptor selectivity profiling against vasopressin receptors, immunoassay calibration, and disulfide mapping.

Compound Specifications

  • Sequence: Cys¹-Tyr-Ile-Gln-Asn-Cys¹-Pro-Leu-Gly-NH₂ (disulfide bridge Cys1-Cys6)
  • Sequence Length: 9 residues (cyclic nonapeptide)
  • Molecular Formula: C₄₃H₆₆N₁₂O₁₂S₂
  • Molecular Weight: ~1007.2 g/mol
  • CAS Number: 50-56-6
  • PubChem CID: 439302
  • Physical Form: Lyophilized powder

 

Storage & Handling
Store lyophilized powder at −20 °C, protected from light. Avoid moisture and repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety practices.

FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

 

Additional information

Weight 0.1 lbs
Dimensions 1 × 1 × 2 in

Disclaimer: For Research Purposes Only

This content is supplied exclusively for research and educational purposes. Nothing presented here should be interpreted as approval, promotion, or encouragement of any non-laboratory use, improper handling, or non-research application of peptides intended for scientific investigation. Any references to specific peptides, their properties, or findings associated with them are provided solely as informational research content. This information does not constitute legal advice, clinical guidance, or a recommendation for personal, therapeutic, or non-research use. These compounds are intended only for controlled scientific work conducted by qualified and authorized individuals. Before making any decision regarding the purchase, possession, handling, or use of research peptides, consultation with qualified research professionals or legal counsel is strongly advised. All information should be used responsibly, ethically, and only in connection with legitimate academic, scientific, or investigative purposes. This notice applies broadly to all peptide-related content provided here and may be updated as needed.

0